back to top
Monday, 7 October, 2024
HomeNews UpdateSwiss police swoop after suicide pod used for first time

Swiss police swoop after suicide pod used for first time

Police in Switzerland have arrested several people after the controversial “Sarco” capsule, designed to allow its occupant to commit suicide, was used for the first time, authorities said this week.

Reuters reports that the capsule was deployed in the woods in the municipality of Merishausen on Monday.

Prosecutors have opened criminal proceedings against several people for “inducing and aiding and abetting suicide”, and several people were detained.

A spokesperson for the group behind the capsule, The Last Resort, said the deceased was a 64-year-old American woman who had been suffering from a severely compromised immune system.

Florian Willet, co-president of The Last Resort, was among the four detainees, along with a Dutch journalist and two Swiss people, a police spokesperson said.

Willet was apparently the only other person present when the woman ended her life.

A spokesperson for The Last Resort said the woman had passed psychiatric evaluations before ending her life.

The “Sarco” causes death when its occupant releases nitrogen gas inside, lowering the amount of oxygen to lethal levels. It is the brainchild of Philip Nitschke, an Australian physician famous for his work on assisted suicide since the 1990s.

Assisted suicide is legal in Switzerland, and The Last Resort says its legal advice was that it could be deployed.

However, Elisabeth Baume-Schneider, the Swiss Minister for health, said on Monday that the capsule does not meet the requirements of product safety law, and that its use of nitrogen is not legally compliant.

 

Reuters article – Swiss police make arrests after suicide capsule is used for first time (Open access)

 

See more from MedicalBrief archives:

 

Why liberal Switzerland is opposing Sarco suicide capsule

 

Euthanasia ‘pod’ ready for use, says inventor

 

Switzerland gives legal approval to suicide pod

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.